Companies: 10,795·Total market cap: $144.5T
CITIC Capital Acquisition Corp.

CITIC Capital Acquisition Corp.

CCACNYSEFinancial Services
$7.05
$-0.37(-4.99%)
Market Cap$0
P/E Ratio
52W High$7.8501
52W Low$7.03

CITIC Capital Acquisition Corp. (CCAC) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

ccac · pe ratio · data through Dec 31, 2020

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for CITIC Capital Acquisition Corp. (CCAC) measures how much investors pay for each dollar of the company's trailing earnings. CCAC's current PE ratio of 188.85x is calculated by dividing its stock price of $7.05 by its TTM earnings per share of $0.04. −32.7% discount vs 5Y avg 280.7x

188.85x
P/E Ratio (TTM)32.7%

Source: FMP · /ratios-ttm · /analyst-estimates · 2020-12-31

Forward P/E
N/A
EPS (TTM)
$0.04
TTM · diluted EPS
PEG Ratio
0.20
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CITIC Capital Acquisition Corp. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2020 – 2020 · Annual
PE Ratio (TTM)
5Y Avg 280.7x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Shell Companies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
CITIC Capital Acquisition Corp.
CITIC Capital Acquisition Corp.You
CCAC
188.85x+126.2%$0.04
Alpha Partners Technology Merger Corp.
Alpha Partners Technology Merger Corp.
APTM
$243MN/A-$31.14
Avalon Acquisition Inc.
Avalon Acquisition Inc.
AVAC
$237M32.49x-61.1%$0.32
BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc.
BBOT
$623MN/A-$4.30
Build Acquisition Corp.
Build Acquisition Corp.
BGSX
$255MN/A-$0.04
Black Spade Acquisition Co
Black Spade Acquisition Co
BSAQ
$221MN/A-$0.19
Frontier Acquisition Corp.
Frontier Acquisition Corp.
FRON
$299M134.46x+61.1%$0.07
Industry Average
2 peers with valid PE
83.48xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 1 of 1 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2020-12-31Latest
FY2020
280.72x$0.04

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for CITIC Capital Acquisition Corp. (CCAC) measures how much investors pay for each dollar of the company's trailing earnings. CCAC's current PE ratio of 188.85x is calculated by dividing its stock price of $7.05 by its TTM earnings per share of $0.04.

PE Ratio = Stock Price ÷ EPS (TTM)
= $7.05 ÷ $0.04 = 188.85x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CCAC pe ratio · 6 questions

CCAC's current PE ratio is 188.85x as of 2026-06-09, based on a stock price of $7.05 and TTM EPS of $0.04. Data sourced from Financial Modeling Prep via CCAC's SEC 10-K and 10-Q filings.

CCAC PE ratioWhat is CCAC PE ratioCurrent PE ratio of CCACCCAC PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CITIC Capital Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09